Terlipressin and Albumin vs Albumin in Patients With Cirrhosis and Hepatorenal Syndrome: A Randomized Study

Gastroenterology

Volumn 134, Issue 5, 2008, Pages 1352-1359

  Martín Llahí, Marta ^a   Pépin, Marie Noëlle ^a   Guevara, Mónica ^a   Díaz, Fernando ^b   Torre, Aldo ^a   Monescillo, Alberto ^c   Soriano, Germán ^d   Terra, Carlos ^a   Fábrega, Emilio ^e   Arroyo, Vicente ^a   Rodés, Juan ^a   Ginès, Pere ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL UNIVERSITARIO PUERTA DEL MAR   (Spain)

^c HOSPITAL UNIVERSITARIO INSULAR DE GRAN CANARIA   (Spain)

^d HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^e HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CREATININE; FUROSEMIDE; NORFLOXACIN; TERLIPRESSIN;

ADULT; AGED; ARTICLE; BACTERIAL INFECTION; BACTERIAL PERITONITIS; BRADYCARDIA; CARDIOVASCULAR DISEASE; CIRCULATORY OVERLOAD; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CREATININE BLOOD LEVEL; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG MECHANISM; DRUG WITHDRAWAL; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEART ARRHYTHMIA; HEART INFARCTION; HEART VENTRICLE EXTRASYSTOLE; HEPATIC ENCEPHALOPATHY; HEPATORENAL SYNDROME; HOSPITALIZATION; HUMAN; HUMAN TISSUE; HYPERTENSION; INTESTINE ISCHEMIA; KIDNEY FUNCTION; LEUKOCYTE COUNT; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FAILURE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SURVIVAL RATE; TERTIARY HEALTH CARE; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; URINE VOLUME;

EID: 42949160648     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2008.02.024     Document Type: Article

References (30)

1. V. Arroyo P. Gines A.L. Gerbes Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis International Ascites Club Hepatology 23 1996 164 176
2. P. Gines M. Guevara V. Arroyo Hepatorenal syndrome Lancet 362 2003 1819 1827
3. S. Nair S. Verma P.J. Thuluvath Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation Hepatology 35 2002 1179 1185
4. C.L. Davis Kidney failure in liver transplantation: it is time for action Am J Transplant 6 2006 2533 2534
5. T.A. Gonwa M.A. McBride K. Anderson Continued influence of preoperative renal function on outcome of orthotopic liver transplant (OLTX) in the US: where will MELD lead us? Am J Transplant 6 2006 2651 2659
6. R. Moreau D. Lebrec Acute renal failure in patients with cirrhosis: perspectives in the age of MELD Hepatology 37 2003 233 243
7. F. Salerno A. Gerbes P. Gines Diagnosis, prevention and treatment of the hepatorenal syndrome in cirrhosis A consensus workshop of the International Ascites Club Gut 56 2007 1310 1318
8. P.Y. Martin P. Gines R.W. Schrier Mechanisms of disease—nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis N Engl J Med 339 1998 533 541
9. M. Guevara P. Gines G. Fernandez-Esparrach Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion Hepatology 27 1998 35 41
10. V. Gulberg M. Bilzer A.L. Gerbes Long-term therapy and retreatment of hepatorenal syndrome type 1 with ornipressin and dopamine Hepatology 30 1999 870 875
11. J. Uriz P. Gines A. Cardenas Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome J Hepatol 33 2000 43 48
12. R. Moreau F. Durand T. Poynard Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study Gastroenterology 122 2002 923 930
13. P. Gines M. Guevara Good news for hepatorenal syndrome Hepatology 36 2002 504 506
14. R. Ortega P. Gines J. Uriz Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study Hepatology 36 2002 941 948
15. R.C. Bone R.A. Balk F.B. Cerra American-College of Chest Physicians Society of Critical Care Medicine Consensus Conference Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis Crit Care Med 20 1992 864 874
16. V. Mazzaferro E. Regalia R. Doci Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis N Engl J Med 334 1996 693 699
17. P. Solanki A. Chawla R. Garg Beneficial effects of terlipressin in hepatorenal syndrome: a prospective, randomized placebo-controlled clinical trial J Gastroenterol Hepatol 18 2003 152 156
18. A. Cardenas P. Gines Management of complications of cirrhosis in patients awaiting liver transplantation J Hepatol 42 2005 S124 S133
19. S.L. Linas J.W. Schaefer E.E. Moore Peritoneovenous shunt in the management of the hepatorenal syndrome Kidney Int 30 1986 736 740
20. A. Gines A. Escorsell P. Gines Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites Gastroenterology 105 1993 229 236
21. L. Ruiz-Del-Arbol J. Urman J. Fernandez Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis Hepatology 38 2003 1210 1218
22. L. Ruiz-Del-Arbol A. Monescillo C. Arocena Circulatory function and hepatorenal syndrome in cirrhosis Hepatology 42 2005 439 447
23. S.S. Lee H. Liu Cardiovascular determinants of survival in cirrhosis Gut 56 2007 746 748
24. G.J. Quinlan G.S. Martin T.W. Evans Albumin: biochemical properties and therapeutic potential Hepatology 41 2005 1211 1219
25. P. Sort M. Navasa V. Arroyo Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis N Engl J Med 341 1999 403 409
26. S.R. Mitzner J. Stange S. Klammt Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial Liver Transpl 6 2000 277 286
27. T.I. Hassanein F. Tofteng R.S. Brown Jr Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis Hepatology 46 2007 1853 1862
28. R.G. Romanelli G. La Villa G. Barletta Long-term albumin infusion improves survival in patients with cirrhosis and ascites: an unblinded randomized trial World J Gastroenterol 12 2006 1403 1407
29. R. Jalan R. Mookerjee L. Cheshire Albumin infusion for severe hyponatremia in patients with refractory ascites: a randomized clinical trial J Hepatol 46 Suppl 1 2007
30. A. Escorsell L.R. Del Arbol R. Planas Multicenter randomized controlled trial of terlipressin versus sclerotherapy in the treatment of acute variceal bleeding: The TEST study Hepatology 32 2000 471 476